Page 177 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY
P. 177
40. Tuomisto LE, Ilmarinen P, Niemela O, Haanpaa J, Kankaanranta T, Kankaanranta H. A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study. Respir Med 2016; 117:223-9.
41. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, et al. A longitudinal, popula - on-based, cohort study of childhood asthma followed to adulthood. New England Journal of Medicine 2003; 349:1414-22.
42. de Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A, Giammanco G. Incidence and remission of asthma: A retrospec ve study on the natural history of asthma in Italy. Journal of Allergy and Clinical Immunology 2002; 110:228-35.
43. Tai A, Tran H, Roberts M, Clarke N, Gibson AM, Vidmar S, et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol 2014; 133:1572-8 e3.
44. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376:803-13.
45. Postma DS, Boezen HM. Ra onale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as gene c factors and their interac on with environment in the development of asthma and COPD. Chest 2004; 126:96S-104S; discussion 59S-61S.
46. Sears MR. Predic ng asthma outcomes. J Allergy Clin Immunol 2015; 136:829-36; quiz 37.
47. Boudier A, Curjuric I, Basagana X, Hazgui H, Anto JM, Bousquet J, et al. Ten-year follow-up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts. Am J Respir Crit Care Med 2013; 188:550-60.
48. Chipps BE, Zeiger RS, Borish L, Wenzel SE, Yegin A, Hayden ML, et al. Key ndings and clinical implica ons from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Journal of Allergy and Clinical Immunology 2012; 130:332-+.
49. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ven latory func on in adults with asthma. New England Journal of Medicine 1998; 339:1194-200.
50. van Veen IH, ten Brinke A, Sterk PJ, Sont JK, Gauw SA, Rabe KF, et al. Exhaled nitric oxide predicts lung func on decline in di cult-to-treat asthma. European Respiratory Journal 2008; 32:344-9.
51. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent air ow limita on in severe or di cult-to-treat asthma. Chest 2007; 132:1882-9.
52. de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, et al. Prognos c factors of asthma severity: A 9-year interna onal prospec ve cohort study. Journal of Allergy and Clinical Immunology 2006; 117:1249-56.
53. Polosa R, Knoke JD, Russo C, Piccillo G, Caponne o P, Sarva M, et al. Cigare e smoking is associated with a greater risk of incident asthma in allergic rhini s. Journal of Allergy and Clinical Immunology 2008; 121:1428-34.
54. Tommola M, Ilmarinen P, Tuomisto LE, Haanpaa J, Kankaanranta T, Niemela O, et al. The e ect of smoking on lung func on: a clinical study of adult-onset asthma. Eur Respir J 2016; 48:1298-306.
55. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72.
56. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Suscep bility to exacerba on in chronic obstruc ve pulmonary disease. N Engl J Med 2010; 363:1128-38.
57. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerba ons of chronic obstruc ve pulmonary disease: iden ca on of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184:662-71.
58. Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal polyposis. Clin Exp Allergy 2015; 45:328-46.
59. Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight: Eosinophilic airway in amma on in nonallergic asthma. Nat Med 2013; 19:977-9.
SUMMARY AND GENERAL DISCUSSION
175
